| Dr Mark A Henderson, MD | |
|
2400 17th St, Columbus, IN 47201-5351 | |
| (812) 376-5550 | |
| (812) 376-5930 |
| Full Name | Dr Mark A Henderson |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 21 Years |
| Location | 2400 17th St, Columbus, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841370707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 01061526A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbus Regional Health Physicians Llc | 1052612314 | 192 |
News Archive
A team of University of Wisconsin-Madison researchers reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.
In the last two years, an "unprecedented" number of CDC staff has resigned or retired from the agency, prompting some officials to express concern, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 9/10).
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.
› Verified 5 days ago
| Entity Name | Columbus Regional Health Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336510098 PECOS PAC ID: 1052612314 Enrollment ID: O20151211000054 |
News Archive
A team of University of Wisconsin-Madison researchers reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.
In the last two years, an "unprecedented" number of CDC staff has resigned or retired from the agency, prompting some officials to express concern, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 9/10).
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark A Henderson, MD Po Box 775383, Chicago, IL 60677-5383 Ph: (812) 376-5315 | Dr Mark A Henderson, MD 2400 17th St, Columbus, IN 47201-5351 Ph: (812) 376-5550 |
News Archive
A team of University of Wisconsin-Madison researchers reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.
In the last two years, an "unprecedented" number of CDC staff has resigned or retired from the agency, prompting some officials to express concern, the Atlanta Journal-Constitution reports (Young, Atlanta Journal-Constitution, 9/10).
Cardiovascular Systems, Inc. has received FDA approval to complete enrollment of 429 patients in its ORBIT II Investigational Device Exemption clinical trial for a coronary application for its Diamondback 360 System.
As scientists continue to search for effective antidotes to direct and indirect damage caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new preprint research paper posted to the bioRxiv* server demonstrates the potential of cannabinoid receptor agonists to alleviate myocardial damage in this condition even in the absence of any inhibitory effect on viral infection as such.
› Verified 5 days ago
Kevin P Mcmullen, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5550 Fax: 812-376-5930 | |
Dr. Frank Michael Mullinix, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 10601 W Grandview Dr, Columbus, IN 47201 Phone: 812-342-4408 | |
Robert A Deweese, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 790 Creekview Dr, Columbus, IN 47201 Phone: 812-373-2113 Fax: 812-373-2114 |